Allergy drug added to immunotherapy benefits lung cancer therapy in small trial Genetic Engineering and Biotechnology News17:11Lung Cancer Cancer Nature

MSD’s Keytruda and Eisai’s Lenvima fail in Phase III uterine cancer trial Pharmaceutical Technology09:34Lenvima Cancer Pharma

Merck says Phase 3 leap-001 trial evaluating Keytruda plus Lenvima did not meet endpoints RTT News07:51Lenvima Cancer Pharma

Radiation therapy may improve cardiac function: Study EasternEye08:32Radiation Cancer

Radiation therapy could potentially improve heart function for heart failure Pharmacy Times10:44Radiation Cancer

AstraZeneca, Absci sign $247M agreement to uncover AI-driven cancer drug candidates MobiHealthNews15:07AstraZeneca Cancer AI

Signal: Absci and AstraZeneca sign deal on AI-powered cancer antibody drug Pharmaceutical Technology10:06AstraZeneca Cancer AI

Hope for men battling hard-to-treat prostate cancer as scientists discover how some tumours… Mail Online11:07Prostate Cancer Cancer Health

Czechia initiates prostate cancer screening programme EurActiv.com01:16Prostate Cancer Cancer Health

CG Oncology’s bladder cancer drug gets fast track to approval Pharmaceutical Technology11:33Cancer FDA Health

Cretostimogene grenadenorepvec confers high CR rate in NMIBC OncLive12:59Cancer FDA Health

Latest News

In the last 2 hours

America's top cancer doctor tells Daily Mail deaths from the disease will be halved by 2050 -… Mail Online08:47

King Charles's top doctor for the royal household 'advocates for homeopathy and argued against… Mail Online08:45

In the last 4 hours

Cellular Therapies in Lymphoma Bring Hope, But Optimizing Their Use Remains a Challenge American Journal of Managed Care08:14

In the last 6 hours

Iowa State expanding pet cancer care as demand booms The Gazette06:35

This Allergy Drug May Help Treat Lung Cancer, Study Finds Knowridge Science Report06:26

In the last 8 hours

Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases Nature.com03:18

Assessing Clinical Trial Efficacy Vs Real-World Effectiveness in the Treatment of Multiple Myeloma Pharmacy Times02:42

Earlier today

AI and Breast Cancer Screening; Cancer After Treatment for Sickle Cell Medpage Today01:42

Bilateral Mastectomy Not Tied to Better Survival in BRCA1-Positive Breast Cancer Medpage Today01:42

Yesterday

Bridging Therapy Prior to Axi-Cel Produces Favorable Real-World Outcomes in R/R LBCL OncLive18:41 9-Dec-23

Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial Nature.com18:11 9-Dec-23

Orca Bio Presents Positive Data Demonstrating the Potential for Orca-T and Orca-Q to Expand… Business Wire (Press Release)17:20 9-Dec-23

'Help, I've got chemotherapy-phobia': Gemma, 35 is among the one in 300 cancer patients afraid… Mail Online17:10 9-Dec-23

Nicrat DG Expresses Concern Over 120,000 Reported New Cancer Cases In Nigeria Independent Nigeria16:25 9-Dec-23

New Hybrid Treatment Forces Cancer Cells to Starve PR Newswire (Press Release)15:04 9-Dec-23

ASH: Targeted oral therapy reduced disease burden and improved symptoms for patients with rare blood disorder Newswise (Press Release)14:04 9-Dec-23

'Our world collapsed after our little girl got brain tumour - this charity was a lifeline' The Mirror13:57 9-Dec-23

Navigating breast cancer decisions / Balancing personal choices and medical insights The Daily Star, Bangladesh13:49 9-Dec-23

ASH: Novel menin inhibitors show promise for patients with advanced acute myeloid leukemias Newswise (Press Release)13:15 9-Dec-23

STAT Plus: Was CAR-T therapy a bystander or driver of lymphoma? Researchers examine first… STAT12:36 9-Dec-23

Scenic Biotech Announces Positive Preclinical Data for its QPCTL Inhibitor SC-2882 as Potential … Business Wire (Press Release)12:35 9-Dec-23

How Neoantigen Vaccines Keep Cancer From Coming Back Discover Magazine12:11 9-Dec-23

First-in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses Newswise (Press Release)12:11 9-Dec-23

New Pivotal Data for Bispecific Antibody Epcoritamab (DuoBody® CD3xCD20) Demonstrates High… Business Wire (Press Release)12:04 9-Dec-23

Nanoparticles Deliver Treatment Directly to Tumors of Deadly Brain Cancer Yale School of Medicine12:00 9-Dec-23

‘120,000 new cancer cases reported yearly in Nigeria’ Vanguard, Nigeria10:09 9-Dec-23

This drug shows promise in treating pancreatic cancer Knowridge Science Report09:15 9-Dec-23

Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ® in… GlobeNewswire (Press Release)08:37 9-Dec-23

New TROPiCS-02 Data Back Sacituzumab Govitecan for Older Patients With Breast Cancer American Journal of Managed Care08:29 9-Dec-23

Prostate cancer treatment first in the West BBC06:04 9-Dec-23

Common ovarian cancer drug not effective, study finds Knowridge Science Report05:53 9-Dec-23

Is Omitting Radiation Therapy in Low-Risk Breast Cancer a Good IDEA? Medpage Today01:27 9-Dec-23

Study Supports ADC as a New Option for Endocrine-Resistant Metastatic Breast Cancer Medpage Today01:27 9-Dec-23

Maintenance Pembrolizumab-Olaparib Fails to Boost Survival in TNBC Medpage Today01:27 9-Dec-23

In the last 7 days

Tennis legend Chris Evert, 68, reveals second ovarian cancer diagnosis since 2021 and says she… Mail Online23:11 8-Dec-23

Low-risk DCIS patients may safely skip radiotherapy after surgery, study finds News-Medical.Net23:07 8-Dec-23

Coroner slams 'poor practice' in treatment of a nurse who died after her cancer was missed by… Mail Online20:29 8-Dec-23

Fully-automated, CT-only GTV contouring for palliative head and neck radiotherapy Nature.com19:56 8-Dec-23

Higher distress levels in Spanish-speaking breast cancer patients undergoing radiation therapy Knowridge Science Report19:43 8-Dec-23

Endocrine Therapy Response Status Is Necessary for Treatment Planning in HR+/HER2– Early Breast Cancer OncLive19:26 8-Dec-23

Women undergoing chemotherapy may not benefit from common fertility protection drug News-Medical.Net19:23 8-Dec-23

Neoadjuvant Nivolumab Plus Carboplatin/Paclitaxel Elicits High pCR Rates in Early-Stage TNBC OncLive18:45 8-Dec-23

POSITIVE Trial Update on Patients With Breast Cancer Attempting Pregnancy American Journal of Managed Care17:03 8-Dec-23

Medical student helps discover her own cancer in ultrasound class ABC7 / KABC-TV16:53 8-Dec-23

Adjuvant T-DM1 Provides Sustained Survival Benefit in HER2+ Early Breast Cancer OncLive16:21 8-Dec-23

No Significant Differences at 5 Year Follow-Up Between Palbociclib-Based Treatment Regimens Pharmacy Times15:28 8-Dec-23

Home-run trials for rare cancers: giving the right drug(s) to the right patients at the right time and in the right… Nature.com14:43 8-Dec-23

Elacestrant Improves PFS in ESR1-Mutant Metastatic Breast Cancer Subgroups OncLive14:19 8-Dec-23

Q&A: How serious is FDA warning about revolutionary blood-cancer treatment? Medical Xpress13:38 8-Dec-23

City of Hope Doctors and Scientists Present Innovative Research at Largest Gathering on Breast… Business Wire (Press Release)13:32 8-Dec-23

Skipping adjuvant radiotherapy may not impact risk of recurrence or progression in patients… Medical Xpress12:47 8-Dec-23

Vittoria’s CAR-T therapy secures clinical approval amid FDA scrutiny on sector Pharmaceutical Technology12:37 8-Dec-23

The Future of Immunotherapy in Breast Cancer Involves Engineered T-Cell Therapies, Better Prediction of Adverse Effects Pharmacy Times12:05 8-Dec-23

Roche's Kadcyla is the first targeted therapy to show significant overall survival benefit in people with HER2-positive … GlobeNewswire (Press Release)11:54 8-Dec-23

Roche’s inavolisib combination reduces the risk of disease progression by 57% in people with advanced hormone… GlobeNewswire (Press Release)11:49 8-Dec-23

Genentech’s Inavolisib Combination Reduces the Risk of Disease Progression by 57% in People… Business Wire (Press Release)11:47 8-Dec-23

New 3D co-cultured model to study effect of proton therapy on aggressive brain cancer Medical Xpress11:16 8-Dec-23

New study questions effectiveness of drugs for ovarian protection during cancer treatment Medical Xpress11:16 8-Dec-23

Lowering Barriers to Care WHYY11:15 8-Dec-23

'Fantastic news': Mum cancer-free after international medical trial New Zealand Herald11:12 8-Dec-23

Pfizer’s multiple myeloma treatment secures conditional approval in EU Pharmaceutical Technology11:05 8-Dec-23

Hong Kong approves 2 new cancer drugs under streamlined application process South China Morning Post10:48 8-Dec-23

High-risk biochemical recurrence of locally treated prostate cancer after EMBARK. An end to decades of conventional… Nature.com10:39 8-Dec-23

Dr Mrinal Gounder: Nirogacestat Approval Provides First-in-Class Option for Desmoid Tumor Treatment American Journal of Managed Care10:37 8-Dec-23

Diabetes, weight-loss drugs like Ozempic may lower odds for colon cancer UPI10:32 8-Dec-23

Diabetes drugs may reduce colorectal cancer risk, suggests study Knowridge Science Report10:03 8-Dec-23

Viral Awakening: The Hidden Threat Of Human Herpes 6 (Hhv-6) In car T Therapy Forbes10:03 8-Dec-23

HER2 low expression breast cancer subtyping and their correlation with prognosis and immune landscape based on the… Nature.com09:34 8-Dec-23

MSD’s Keytruda and Eisai’s Lenvima fail in Phase III uterine cancer trial Pharmaceutical Technology09:34 8-Dec-23

Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of… GlobeNewswire (Press Release)09:16 8-Dec-23

Xenon’s $345 million public offering; BioVie’s Alzheimer’s trial success; gene therapy found to reduce liver cancer Labiotech09:02 8-Dec-23

Women With Very Early Breast Cancer May Safely Skip Radiation Rx: Study U.S. News & World Report08:57 8-Dec-23

Lymphedema Left her 'Miserable, Depressed' Until Specialized Surgery Changed Everything U.S. News & World Report08:57 8-Dec-23

Some Early Breast Cancer Patients Can Skip Radiation NewsMax08:44 8-Dec-23

Rigel Pharma Enters Alliance With MD Anderson To Evaluate REZLIDHIA - Quick Facts RTT News08:32 8-Dec-23

Intensity Therapeutics Presents Positive INT230-6 Data in Patients with Early-Stage Breast… PR Newswire (Press Release)08:31 8-Dec-23

Menarini Group Presents New Progression-Free Survival Data from EMERALD Clinical Study of… Business Wire (Press Release)08:07 8-Dec-23

NiKang Therapeutics Enters into Clinical Trial Collaboration and Supply Agreement to Evaluate… Business Wire (Press Release)08:03 8-Dec-23

European Commission Approves Pfizer’s ELREXFIO® for Relapsed and Refractory Multiple Myeloma Pfizer (Press Release)08:00 8-Dec-23

Merck Says Phase 3 LEAP-001 Trial Evaluating KEYTRUDA Plus LENVIMA Did Not Meet Endpoints RTT News07:51 8-Dec-23

Gene therapy reduces hepatocellular carcinoma in mice Drug Target Review07:08 8-Dec-23

Merck-Eisai's uterine cancer therapy combo fails first-line treatment trial Reuters07:08 8-Dec-23

Merck and Eisai Provide Update on Phase 3 LEAP-001 Trial Evaluating (pembrolizumab) Plus… Business Wire (Press Release)06:47 8-Dec-23

Exercise can improve metastatic breast cancer patients' quality of life, study finds PhillyVoice06:39 8-Dec-23

New options for late-line treatment of metastatic colorectal cancer Nature.com06:34 8-Dec-23

AI can boost cancer drug development, study finds Knowridge Science Report06:28 8-Dec-23

Medical microrobots that can travel inside your body are (still) on their way MIT Technology Review06:10 8-Dec-23

Mehdi Astaraki wins prestigious international challenge on image segmentation for radiation therapy Research News06:09 8-Dec-23

Injectable anti-cancer drug unveiled in Iran Mehr News Agency04:51 8-Dec-23

Young cancer patient’s double celebration marks the end of her treatment Medway NHS Foundation Trust (Press Release)04:32 8-Dec-23

Arthritis drug could offer immunotherapy hope in type 1 diabetes Diabetes UK04:24 8-Dec-23

Adding Immunotherapy to Neoadjuvant Chemo Boosts pCR in HR-Positive Breast Cancer Medpage Today02:02 8-Dec-23

GLP-1 Drugs Linked to Lower Colorectal Cancer Risk for Diabetes Patients Medpage Today02:02 8-Dec-23

Detecting Ovarian Cancer Early; Allergy Med for NSCLC? Bad News for Anti-TIGIT Drug Medpage Today02:02 8-Dec-23

The Treatment Landscape for Cervical Cancer Has Changed Medpage Today02:02 8-Dec-23

No Benefit to Adjuvant-Only Immunotherapy in Early TNBC Medpage Today02:02 8-Dec-23

Roche's double-antibody DLBCL treatment Columvi nabs Korean nod Korea Biomedical Review01:54 8-Dec-23

Real world data on outcomes of anti-CD38 antibody treated, including triple class refractory, patients with multiple… Nature.com01:50 8-Dec-23

Immutep Receives A$2.6 million R&D Tax Incentive from French Government BioSpace00:22 8-Dec-23

Heat shock protein HSPA13 promotes hepatocellular carcinoma progression by stabilizing TANK Nature.com23:58 7-Dec-23

Fused pancreatic cancer organoid system captures tumor heterogeneity and drug resistance News-Medical.Net23:54 7-Dec-23

Study identifies new target for fatty liver disease treatment News-Medical.Net23:34 7-Dec-23

Apoptosis Regulator BAX drugs in development, 2023 Pharmaceutical Technology23:32 7-Dec-23

Fibroblast Growth Factor 2 drugs in development, 2023 Pharmaceutical Technology23:32 7-Dec-23

Histone Deacetylase 8 drugs in development, 2023 Pharmaceutical Technology23:32 7-Dec-23

Protein Kinase C Theta Type drugs in development, 2023 Pharmaceutical Technology23:32 7-Dec-23

Bromodomain Testis Specific Protein drugs in development, 2023 Pharmaceutical Technology23:22 7-Dec-23

Protein Kinase C Epsilon Type drugs in development, 2023 Pharmaceutical Technology23:12 7-Dec-23

Nicotinamide Phosphoribosyltransferase drugs in development, 2023 Pharmaceutical Technology23:12 7-Dec-23

Catenin Beta 1 drugs in development, 2023 Pharmaceutical Technology23:02 7-Dec-23

Retinoic Acid Receptor Gamma drugs in development, 2023 Pharmaceutical Technology23:02 7-Dec-23

Tyrosine Protein Kinase SYK drugs in development, 2023 Pharmaceutical Technology22:51 7-Dec-23

Leucine Rich Repeat Serine/Threonine Protein Kinase 2 drugs in development, 2023 Pharmaceutical Technology22:51 7-Dec-23

Histone Deacetylase 1 drugs in development, 2023 Pharmaceutical Technology22:51 7-Dec-23

Cyclin Dependent Kinase 2 drugs in development, 2023 Pharmaceutical Technology22:51 7-Dec-23

view more headlines

10 Dec 08:47

About our Cancer Treatment news...

Latest news on Cancer Treatment including updates on radiotherapy, chemotherapy, immunotherapy, funding, trials and developments.

Cancer Treatment

Latest News

About our Cancer Treatment news...

Cancer Top Stories

Health Top Stories

Lifestyle Top Stories